CSII Cardiovascular Systems Inc.
- 0 P/E
- 4.18 P/S
- 5.86 P/B
- -1.07 EPS
- 44.07% Cash ROIC
- 1.39 Cash Ratio
- 0 / 0% Dividend
- 197,345.00 Avg. Vol.
- 15.92M Shares
- 410.2M Market Cap.
Cardiovascular Systems, Inc., a medical device company, focuses on developing and commercializing interventional treatment systems for vascular disease. Its primary product, the Diamondback 360°, is a minimally invasive catheter system for the treatment of peripheral arterial disease and a range of plaque types in leg arteries. The Diamondback 360° consists of a single-use catheter that travels ...
Insider Monkey (blog) - Apr 19, 2013
4-traders (press release) - Apr 24, 2013
DailyFinance - May 2, 2013
GlobeNewswire (press release) - May 2, 2013
Empowered News (press release) - May 14, 2013
Fox Business - Apr 30, 2013
Tesla among companies subpoenaed about director stock trades - Silicon Valley Business Journal
Mideast Time - May 6, 2013
MarketsNTrade - May 14, 2013
Phoenix Business Journal (blog) - 9 hours ago
MarketsNTrade - May 17, 2013